Prostate Specific Antigen (PSA) Screening

The aim of screening is to pick up certain conditions or cancers before you have symptoms. Early diagnosis allows for early treatment, and hopefully less chance of risk to your health and ultimately to reduce your risk of dying early.

The World Health Organisation (WHO) sets the standard for what makes a good screening test – broadly they need to be reliable, accurate and have an obvious treatment path. The test needs be acceptable to the person being screened, relatively easy and inexpensive to do, and it needs to be a test for an important health condition.

The PSA test as a screen falls short of some of these components, which is why it’s not offered in the UK routinely. Prostate cancer certainly is an important health condition – it's the most common cancer to affect men in the UK with over 52,000 cases being diagnosed every year. It usually has a good outlook in that in most men it doesn’t spread to other parts of the body, and even if it has spread around half of men with this stage of prostate cancer are alive 5 years after their diagnosis is made.

The screening usually involves both a blood test to check the PSA level, and an intimate examination, called a digital rectal exam. This is where the surface and size of the prostate can be felt with a finger via the back passage. It can be uncomfortable and feel a bit embarrassing, but it’s not usually painful, and it’s over quite quickly.

A PSA test can help pick up prostate cancer before you have any symptoms and before it becomes widespread, giving a chance for earlier treatment. For those with an increased risk of prostate cancer, it can be helpful to check PSA levels, and perhaps make it a regular check. It can also be reassuring if it’s normal.

There are several disadvantages, which is why it’s important to weigh these up in discussion with your doctor.

A number of conditions besides prostate cancer can raise your PSA level. This is a so-called false positive result, where the raised PSA suggests cancer, where there is actually no cancer, and can occur in up to 3 out of every 4 men taking the test.

This leads to significant anxiety and sometimes invasive investigations that can be uncomfortable, time-consuming, worrisome, and may risk side effects or damage to the prostate or nearby structures, such as taking a biopsy of prostate tissue. This may be worth the risk in cancer, but not if the tests are unnecessary in the first place.

Similarly, it doesn’t differentiate between a slow-growing cancer that may never cause problems and may not shorten your life, compared with an aggressive cancer that needs radical treatment. This causes considerable anxiety for you and dilemmas about further invasive procedures that may be unnecessary.

It can be falsely reassuring if you have prostate cancer but you have a normal PSA level. This means some cases would be missed by acting only on the PSA result, rather than considering any relevant symptoms, and this is called a false negative. The PSA test can miss nearly 1 in 7 cancers.

Treatment involves either surgery or radiotherapy, both of which can cause significant side effects and risk of damage. This makes it important to ensure that treatment is not undertaken without good reason.

It's ultimately a very personal decision, and after trying to reason through all of the pros and the cons, you may simply decide that if a test is available, you want to know the result either way. Or you may feel strongly that you'd rather not know, and if symptoms or signs occur you can deal with these then.